Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort …
…, C Thibeault, S Jentzsch, ET Helbig… - The Lancet …, 2021 - thelancet.com
Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19
…, D Ludwig, C Correia-Melo, SK Aulakh, ET Helbig… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …
to severe organ damage and death. We characterized the time-dependent progression of …
[HTML][HTML] Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01
…, V Ilinsky, I Popov, J Balnis, A Jaitovich, ET Helbig… - …, 2021 - thelancet.com
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
there has been increasing urgency to identify pathophysiological characteristics leading to …
there has been increasing urgency to identify pathophysiological characteristics leading to …
[HTML][HTML] Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses
…, S Thada, K Dietert, L Bauer, A Schäfer, ET Helbig… - Nature …, 2018 - nature.com
Live attenuated vaccines are generally highly efficacious and often superior to inactivated
vaccines, yet the underlying mechanisms of this remain largely unclear. Here we identify …
vaccines, yet the underlying mechanisms of this remain largely unclear. Here we identify …
[PDF][PDF] Complement activation induces excessive T cell cytotoxicity in severe COVID-19
…, I Gemünd, M Barone, P Tober-Lau, ET Helbig… - Cell, 2022 - cell.com
Severe COVID-19 is linked to both dysfunctional immune response and unrestrained
immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, …
immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, …
[HTML][HTML] Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany
…, P Tober-Lau, D Hillus, ET Helbig… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
…, E Binatti, E Scarpini, ET Helbig… - Human molecular …, 2022 - academic.oup.com
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a
deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our …
deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our …
[HTML][HTML] A proteomic survival predictor for COVID-19 patients in intensive care
…, C Correia-Melo, LJ Lippert, ET Helbig… - PLOS Digital …, 2022 - journals.plos.org
Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to
optimize allocation of treatment and resources in intensive care, as clinically established risk …
optimize allocation of treatment and resources in intensive care, as clinically established risk …
[HTML][HTML] Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic …
…, B Mühlemann, ET Helbig, M Mittermaier, T Lingscheid… - Infection, 2021 - Springer
Purpose Adequate patient allocation is pivotal for optimal resource management in strained
healthcare systems, and requires detailed knowledge of clinical and virological disease …
healthcare systems, and requires detailed knowledge of clinical and virological disease …
[HTML][HTML] Outbreak of SARS-CoV-2 B. 1.1. 7 lineage after vaccination in long-term care facility, Germany, February–March 2021
…, D Hillus, J Spieckermann, ET Helbig… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
One week after second vaccinations were administered, an outbreak of B. 1.1. 7 lineage
severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility …
severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility …